Anorectal diseases
Conditions
Interventions
Hydromorphone combined with ropivacaine intrathecal anesthesia group (H group):Intrathecal injection of hydromorphone combined with ropivacaine
Ropivacaine intrathecal anesthesia group (C group):Intrathecal injection of ropivacaine
Sponsors
Deyang People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with benign anorectal diseases (haemorrhoids, anal fissure, anal fistula, perianal abscess, acromegaly, etc.) who are scheduled to undergo surgical treatment; 2. Age 18 years or older; 3. ASA classification I-III.
Exclusion criteria
Exclusion criteria: 1. Allergy or intolerance to the study drug; 2.History of chronic pain or prolonged preoperative use of analgesics; 3. Coagulation disorders and administration of anticoagulant drugs; 4. History of spinal trauma or surgery; 5. Incomplete conversion of intrathecal anaesthesia to general anaesthesia. 5. Refusal of the patient to co-operate and early withdrawal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of postoperative analgesia;Pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions (including sedation level and degree of nausea and itching);Consumption of opioids;Patient satisfaction; | — |
Countries
China
Contacts
Public ContactZhang Xianjie
Deyang People's Hospital
Outcome results
None listed